Related references
Note: Only part of the references are listed.TRPV2 channel-based therapies in the cardiovascular field. Molecular underpinnings of clinically relevant therapies
Brian O'Connor et al.
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2021)
Treatment with 24hour istaroxime infusion in patients hospitalised for acute heart failure: a randomised, placebo-controlled trial
Valentina Carubelli et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction Rationale and Design of GALACTIC-HF
John R. Teerlink et al.
JACC-HEART FAILURE (2020)
Probenecid treatment improves outcomes in a novel mouse model of peripartum cardiomyopathy
Evan Onusko et al.
PLOS ONE (2020)
Trends in Readmission and Mortality Rates Following Heart Failure Hospitalization in the Veterans Affairs Health Care System From 2007 to 2017
Justin T. Parizo et al.
JAMA CARDIOLOGY (2020)
Probenecid Improves Cardiac Function in Subjects with a Fontan Circulation and Augments Cardiomyocyte Calcium Homeostasis
Jack Rubinstein et al.
PEDIATRIC CARDIOLOGY (2020)
Effects of Omecamtiv Mecarbil on Symptoms and Health-Related Quality of Life in Patients With Chronic Heart Failure Results From the COSMIC-HF Study
G. Michael Felker et al.
CIRCULATION-HEART FAILURE (2020)
Cardiac Calcitropes, Myotropes, and Mitotropes JACC Review Topic of the Week
Mitchell A. Psotka et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Cardiovascular Risks of Probenecid Versus Allopurinol in Older Patients With Gout
Seoyoung C. Kim et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Epidemiology of Left Ventricular Systolic Dysfunction and Heart Failure in the Framingham Study An Echocardiographic Study Over 3 Decades
Ramachandran S. Vasan et al.
JACC-CARDIOVASCULAR IMAGING (2018)
Probenecid Improves Cardiac Function in Patients With Heart Failure With Reduced Ejection Fraction In Vivo and Cardiomyocyte Calcium Sensitivity In Vitro
Nathan Robbins et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Use of Inotropic Agents in Treatment of Systolic Heart Failure
Sohaib Tariq et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Guidelines for the Use of Echocardiography as a Monitor for Therapeutic Intervention in Adults: A Report from the American Society of Echocardiography
Thomas R. Porter et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2015)
ACSM's New Preparticipation Health Screening Recommendations from ACSM's Guidelines for Exercise Testing and Prescription, Ninth Edition
Paul D. Thompson et al.
CURRENT SPORTS MEDICINE REPORTS (2013)
Probenecid as a Noninjurious Positive Inotrope in an Ischemic Heart Disease Murine Model
Sheryl E. Koch et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2013)
The History and Future of Probenecid
Nathan Robbins et al.
CARDIOVASCULAR TOXICOLOGY (2012)
Probenecid: Novel use as a non-injurious positive inotrope acting via cardiac TRPV2 stimulation
Sheryl E. Koch et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)
TRPV2 is a component of osmotically sensitive cation channels in murine aortic myocytes
K Muraki et al.
CIRCULATION RESEARCH (2003)
Sample size re-estimation: recent developments and practical considerations
AL Gould
STATISTICS IN MEDICINE (2001)
EQ-5D: a measure of health status from the EuroQol Group
R Rabin et al.
ANNALS OF MEDICINE (2001)
Share Paper
